Abstract
Ductal carcinoma in situ (DCIS) is the most common precursor of invasive breast cancer (IBC), with variable propensity for progression. We perform multiscale, integrated molecular profiling of DCIS with clinical outcomes by analyzing 774 DCIS samples from 542 patients with 7.3 years median follow-up from the Translational Breast Cancer Research Consortium 038 study and the Resource of Archival Breast Tissue cohorts. We identify 812 genes associated with ipsilateral recurrence within 5 years from treatment and develop a classifier that predicts DCIS or IBC recurrence in both cohorts. Pathways associated with recurrence include proliferation, immune response, and metabolism. Distinct stromal expression patterns and immune cell compositions are identified. Our multiscale approach employed in situ methods to generate a spatially resolved atlas of breast precancers, where complementary modalities can be directly compared and correlated with conventional pathology findings, disease states, and clinical outcome.
Original language | English |
---|---|
Pages (from-to) | 1521-1536.e7 |
Journal | Cancer Cell |
Volume | 40 |
Issue number | 12 |
DOIs | |
State | Published - Dec 12 2022 |
Keywords
- RNA gene expression profiling
- breast
- classifier
- ductal carcinoma in situ
- multiplex immunohistochemistry
- precancer
- prognosis
- progression
- tumor microenvironment
- whole genome sequencing